Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
出版年份 2021 全文链接
标题
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
作者
关键词
-
出版物
ACS Medicinal Chemistry Letters
Volume 12, Issue 8, Pages 1325-1332
出版商
American Chemical Society (ACS)
发表日期
2021-07-15
DOI
10.1021/acsmedchemlett.1c00326
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- What coronavirus 3C‐like protease tells us: From structure, substrate selectivity, to inhibitor design
- (2021) Muya Xiong et al. MEDICINAL RESEARCH REVIEWS
- Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
- (2021) Hylemariam Mihiretie Mengist et al. Frontiers in Pharmacology
- Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
- (2021) Chun-Hui Zhang et al. ACS Central Science
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
- (2020) Jared S. Morse et al. CHEMBIOCHEM
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- Lack of Antiviral Activity of Darunavir against SARS-CoV-2
- (2020) Sandra De Meyer et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Chemistry and Biology of SARS-CoV-2
- (2020) Alexander Dömling et al. Chem
- Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
- (2020) Mohammad M. Ghahremanpour et al. ACS Medicinal Chemistry Letters
- Mechanistic Development and Recent Applications of the Chan–Lam Amination
- (2019) Matthew J. West et al. CHEMICAL REVIEWS
- Drug permeability profiling using cell-free permeation tools: Overview and applications
- (2018) Philippe Berben et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations
- (2017) Zoe Cournia et al. Journal of Chemical Information and Modeling
- LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands
- (2017) Leela S. Dodda et al. NUCLEIC ACIDS RESEARCH
- Computer-aided discovery of anti-HIV agents
- (2016) William L. Jorgensen BIOORGANIC & MEDICINAL CHEMISTRY
- Systematic Study of Effects of Structural Modifications on the Aqueous Solubility of Drug-like Molecules
- (2016) José A. Cisneros et al. ACS Medicinal Chemistry Letters
- Improved Peptide and Protein Torsional Energetics with the OPLS-AA Force Field
- (2015) Michael J. Robertson et al. Journal of Chemical Theory and Computation
- Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
- (2015) Lingle Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Efficient Drug Lead Discovery and Optimization
- (2009) William L. Jorgensen ACCOUNTS OF CHEMICAL RESEARCH
- Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound
- (2007) Edit Baka et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More